diabetes - Nursing Case Study
Pathophysiology
• Primary mechanism: Insulin deficiency or resistance impairs glucose uptake by cells, leading to elevated blood glucose levels. In Type 1 diabetes, autoimmune destruction of pancreatic beta cells results in insulin deficiency. In Type 2 diabetes, peripheral tissues become resistant to insulin's effects, often accompanied by inadequate insulin secretion.
• Secondary mechanism: Chronic hyperglycemia causes glycation of proteins and lipids, leading to the formation of advanced glycation end-products (AGEs). These AGEs contribute to endothelial damage and inflammation, promoting complications like nephropathy, retinopathy, and neuropathy.
• Key complication: Persistent high blood glucose levels can lead to microvascular and macrovascular complications, increasing the risk of cardiovascular disease, kidney failure, vision loss, and peripheral nerve damage, significantly impacting quality of life and requiring ongoing management.
Patient Profile
Demographics:
55-year-old male, office manager
History:
• Key past medical history: Type 2 diabetes diagnosed 8 years ago, hypertension, hyperlipidemia
• Current medications: Metformin, lisinopril, atorvastatin, aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing fatigue and intermittent blurry vision
• Key symptoms: Numbness in feet, frequent urination, excessive thirst, occasional dizziness
• Vital signs: Blood pressure 145/90 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, HbA1c 8.5%
Section 1
As the healthcare team continues to monitor the 55-year-old male patient with type 2 diabetes, new diagnostic results offer deeper insights into his condition, revealing the progression of complications. Recent laboratory tests indicate a worsening renal function, with serum creatinine levels elevated at 1.8 mg/dL (normal range: 0.6-1.2 mg/dL) and an eGFR of 45 mL/min/1.73m², suggesting stage 3 chronic kidney disease. Additionally, urine microalbumin levels are found to be significantly elevated at 150 mg/dL, confirming the onset of diabetic nephropathy. These findings correlate with the patient's symptoms of increased fatigue and frequent urination, which may be exacerbated by declining kidney function.
Further examination of the patient's fundoscopic exam reveals early signs of diabetic retinopathy, characterized by microaneurysms and cotton wool spots. This aligns with his complaint of intermittent blurry vision and underscores the need for regular ophthalmologic follow-up to prevent further vision deterioration. The patient's numbness in the feet, coupled with decreased vibratory sensation and diminished ankle reflexes, suggests a progression of peripheral neuropathy, raising concerns about potential foot ulcers and the need for diligent foot care and monitoring.
These diagnostic findings necessitate a reevaluation of the patient's management plan. The team considers intensifying glycemic control by adjusting his current medications or introducing additional therapies to prevent further complications. The healthcare team discusses the importance of lifestyle modifications, including dietary changes and increased physical activity, to help manage his blood glucose levels and mitigate cardiovascular risks. Regular follow-ups and a multidisciplinary approach, involving nephrology and ophthalmology consultations, are emphasized to address the evolving complications and improve the patient's overall quality of life.
Section 2
Response to Interventions:
Following the intensification of the patient's glycemic control regimen, which included the introduction of an SGLT2 inhibitor, there have been notable changes in his clinical status. The patient reports feeling slightly more energetic and experiencing less frequent urination, suggesting a positive initial response to the medication adjustment. His most recent HbA1c level has shown a modest improvement, decreasing from 8.5% to 7.8%, indicating better overall blood glucose management. However, despite these improvements, the patient continues to experience intermittent blurry vision, which is concerning for ongoing retinal changes.
In terms of renal function, repeat laboratory tests show a slight decline in serum creatinine to 1.7 mg/dL and an eGFR that remains stable at 45 mL/min/1.73m². This suggests a stabilization of the renal function, likely due to the renal-protective effects of the SGLT2 inhibitor. Nevertheless, the patient must maintain strict dietary adherence to low sodium and protein intake to sustain kidney health. Additionally, the patient's blood pressure, recorded at 135/85 mmHg, indicates a need for better hypertension management to further protect renal and ophthalmologic health.
Despite the small victories in glycemic and renal parameters, the patient has developed a small, non-healing ulcer on his left foot, measuring approximately 1.5 cm in diameter. This new complication underscores the importance of vigilant foot care and necessitates the involvement of a podiatrist for specialized wound management. The healthcare team emphasizes the need for patient education on proper foot inspection and footwear, aiming to prevent further deterioration and potential infections. This development in the patient's condition calls for a reassessment of his overall care plan, ensuring continued improvement in both microvascular and macrovascular health outcomes.
Section 3
New Complications:
Despite initial improvements in glycemic control and renal function stabilization, the patient's condition has taken a concerning turn with the development of peripheral neuropathy. The patient reports experiencing a tingling sensation and numbness in both feet, which has progressively worsened over the past few weeks. This new complication is likely a result of prolonged hyperglycemia and highlights the need for a comprehensive neurological assessment. During the examination, the monofilament test reveals diminished sensation in the toes and the ball of the foot, indicating significant sensory loss. Additionally, the patient's Achilles tendon reflexes are absent bilaterally, confirming the presence of neuropathy.
This development necessitates a multidisciplinary approach to prevent further complications and improve the patient's quality of life. Given the risk of diabetic foot ulcers and potential amputations, the healthcare team must reinforce the importance of daily foot inspections and appropriate footwear. A referral to a neurologist is made for further evaluation and management of the neuropathy, which may include the use of medications such as gabapentin or pregabalin to alleviate neuropathic pain.
From a broader perspective, the patient's hypertension management also needs to be optimized to reduce the risk of additional microvascular complications. A review of his antihypertensive regimen is undertaken, considering the addition of an ACE inhibitor or angiotensin II receptor blocker, which would offer both blood pressure control and renal protection. The patient's journey highlights the interconnected nature of diabetes complications, underscoring the importance of a holistic and proactive approach to care, which will be crucial in addressing this latest challenge and preventing further deterioration.
Section 4
Change in Patient Status:
In the weeks following the introduction of interventions aimed at managing the patient's peripheral neuropathy and optimizing hypertension control, there is a noticeable shift in his overall condition. The patient reports a partial reduction in the tingling sensation and numbness in his feet since starting gabapentin, although he continues to experience significant discomfort when ambulating. During a follow-up appointment, his vital signs indicate a blood pressure of 138/82 mmHg, which shows mild improvement following the adjustment of his antihypertensive regimen to include an ACE inhibitor.
Laboratory results reveal a hemoglobin A1c of 8.5%, indicating that while there has been some progress in glycemic control, further efforts are necessary to reach the target range. Additionally, recent renal function tests show stable creatinine levels, suggesting a temporary halt in renal deterioration. However, the patient now presents with new skin changes in the lower extremities, including dry, cracked skin on the heels and signs of early-stage callus formation on the metatarsal heads. These findings prompt the healthcare team to intensify their education on foot care practices and re-evaluate the patient's footwear to prevent skin breakdown and ulceration.
This change in the patient's status emphasizes the critical need for continued, diligent management of his diabetes and associated complications. The healthcare team focuses on reinforcing lifestyle modifications, such as dietary adjustments and regular physical activity, as part of a comprehensive care plan. By maintaining a proactive approach, the team aims to prevent further complications and enhance the patient's quality of life. Regular follow-ups and the incorporation of a podiatrist into the care team are planned to closely monitor and address any emerging concerns, ensuring a coordinated effort in managing the patient's complex medical needs.
Section 5
As the patient's care continues, the healthcare team notes a developing complication during a routine follow-up appointment. The patient reports increased difficulty in ambulating due to escalating pain and discomfort in his lower extremities. Upon examination, there is noticeable swelling and redness around the ankles and feet, and a small ulcer has developed on the left heel. The ulcer appears superficial but is surrounded by erythema, raising concerns for potential infection. This finding prompts immediate attention from the healthcare team, who conduct a thorough assessment to determine the extent of the complication.
Recent laboratory results provide additional insights into the patient's evolving condition. His white blood cell count is elevated at 12,000/mm³, suggesting an inflammatory response, possibly due to the developing ulcer. The patient’s fasting blood glucose level is recorded at 180 mg/dL, indicating suboptimal control of diabetes despite ongoing efforts. The patient's creatinine remains stable, but there is a noted increase in microalbuminuria, now at 45 mg/g, which may signify early nephropathy progression. These diagnostic findings necessitate a multidisciplinary approach to address the current complications effectively.
In response to these developments, the healthcare team prioritizes the management of the patient's ulcer and potential infection. An immediate referral to a podiatrist for specialized wound care is arranged, along with the initiation of a broad-spectrum antibiotic to preemptively treat any possible infection. The team also revisits the patient's diabetes management plan, emphasizing the importance of strict glycemic control to aid in wound healing and prevent further deterioration. Additionally, the introduction of a diabetic foot care specialist to the team is considered, focusing on preventive measures and patient education to mitigate the risk of future complications. This comprehensive approach aims to stabilize the patient's condition and prevent further adverse outcomes, setting the stage for continued monitoring and tailored interventions.